STOCK TITAN

MANHATTAN ASSOCIATES (MANH) SEC Filings

MANH NASDAQ

Manhattan Associates Inc. filings document operating results, governance and executive compensation for a Georgia-incorporated supply chain and omnichannel commerce software company. Form 8-K reports furnish quarterly earnings releases and discuss GAAP results alongside adjusted operating income, adjusted net income and adjusted diluted earnings per share.

The company’s regulatory record also includes current reports on officer succession and related compensation arrangements, including restricted stock units and executive employment terms. Its definitive proxy materials cover board and shareholder matters, executive pay tables, equity awards and pay-versus-performance disclosures.

Rhea-AI Summary

Manhattan Associates (MANH) director Linda T. Hollembaek sold 1,315 shares of common stock at $250 per share on November 3, 2026. She directly held 10,953 shares after the sale. Both the sale and the remaining position are listed as direct ownership. No Rule 10b5-1 plan is reported for the sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Manhattan Associates director Linda T. Hollembaek filed a notice to sell 1,315 common shares, with an approximate sale date of November 3, 2026, and an aggregate market value of $328,750.00. The shares are identified as 161 shares from restricted stock vesting on May 12, 2022, and 1,154 shares from vesting on May 13, 2025. The notice lists her sale of 1,579 shares on August 6, 2026, for $299,820.68 during the prior three months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.07%
Tags
other
-
Rhea-AI Summary

Manhattan Associates (MANH) reported third-quarter 2026 revenue of $306.2 million, up 11% from $275.8 million a year earlier. Cloud subscription revenue rose 28% to $134.4 million; diluted earnings per share were $1.04, versus $0.96. Operating income was $81.0 million, while operating margin was 26.5%, compared with 27.5%.

For the first nine months, revenue increased 9% to $886.2 million and cloud subscriptions revenue grew 26% to $378.3 million. Net income declined to $161.0 million from $168.0 million, and diluted earnings per share were $2.72 versus $2.75. Operating margin was 23.9%, compared with 26.2%, while operating cash flow was $243.3 million versus $242.4 million.

Manhattan Associates repurchased approximately $325.0 million of common stock during the nine months and ended September 30, 2026 with $199.4 million in cash and no debt. On June 1, 2026, the company reduced global headcount by approximately 6%; it recorded $8.3 million in pretax restructuring expense, reducing net income by approximately $6.2 million, or $0.11 per fully diluted share. Remaining performance obligations were approximately $2.6 billion, up 25% year over year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.13%
Tags
quarterly report
Rhea-AI Summary

Manhattan Associates (MANH) reported third-quarter revenue of $306.2 million, versus $275.8 million a year earlier. GAAP diluted EPS was $1.04 versus $0.96; adjusted diluted EPS, a non-GAAP measure, was $1.55 versus $1.36. Cloud revenue rose 28% year over year to $134.4 million, and remaining performance obligations (RPO) increased 25% to $2.59 billion.

Full-year 2026 guidance is revenue of $1,176 million to $1,178 million, adjusted operating margin of 35.2% to 35.4%, and adjusted EPS of $5.54 to $5.56. Q3 cash flow from operations was $68.6 million, down from $93.1 million; Manhattan repurchased 244,748 shares for $50.0 million. On June 1, 2026, a restructuring reduced global headcount by approximately 6%.

Bylaw amendments effective October 22, 2026, require at least 1% of outstanding common stock ownership, at the time of the challenged act or omission, to bring a derivative proceeding. They designate the Georgia State-wide Business Court for internal entity claims and U.S. federal district courts for Securities Act claims, unless the company consents in writing to another forum. The board elected Juan Perez as a Class III director, with service expected to begin January 28, 2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.46%
Tags
current report
-
Rhea-AI Summary

AllianceBernstein L.P. filed Amendment No. 1 to a Schedule 13G reporting its passive ownership in Manhattan Associates Inc. common stock. AllianceBernstein reports beneficial ownership of 2,297,954 shares, representing 3.9% of the outstanding common stock, held for investment on behalf of client discretionary investment advisory accounts. It has sole voting power over 2,222,710 shares and sole dispositive power over 2,247,706 shares, with shared dispositive power over 50,248 shares and no shared voting power. The filing notes that AllianceBernstein is a majority-owned subsidiary of Equitable Holdings, Inc. but operates under independent management, and Equitable Holdings calculates and reports beneficial ownership separately. The filing also confirms that AllianceBernstein’s holdings are 5 percent or less of the class.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.76%
Tags
ownership
-
Rhea-AI Summary

Manhattan Associates Inc. President & CEO Eric Andrew Clark reported a sale of 3,000 shares of common stock on 2026-08-11 in an open-market or private transaction at $197.76 per share. Following this transaction, he directly holds 89,638 shares of Manhattan Associates common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
insider
Rhea-AI Summary

Manhattan Associates Inc insider Eric Clark, identified as CEO, filed to sell 3,000 shares of common stock through UBS Financial Services Inc, with an indicated aggregate market value of $592,962.53 and listing on NASDAQ. The filing also notes a prior grant of 8,666 shares of common stock to Clark on February 14, 2025 and a sale of 1,000 shares of common stock on June 10, 2026 for $146,770.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
other
-
Rhea-AI Summary

MANHATTAN ASSOCIATES INC director Linda T. Hollembaek reported a sale of company stock. On 2026-08-06, she sold 1,579 shares of common stock at an average price of $189.8801 per share in an open market or private transaction. Following this sale, she directly holds 12,268 shares of MANHATTAN ASSOCIATES INC common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
insider
-
Form 144
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.41%
Tags
other
Rhea-AI Summary

FMR LLC filed an amended Schedule 13G reporting beneficial ownership of the common stock of Manhattan Associates Inc. as of June 30, 2026. FMR LLC reported beneficial ownership of 3,611,292.17 shares of common stock, representing 6.1% of the class, with sole dispositive power over these shares and sole voting power over 3,600,195.74 shares.

Abigail P. Johnson is also reported as a beneficial owner of the same 3,611,292.17 shares, representing 6.1% of the outstanding common stock, with sole dispositive power and no voting power. The filing notes that one or more other persons have rights to dividends or sale proceeds, including Select Technology Portfolio, whose interest amounted to 3,123,214.00 shares, or 5.3% of Manhattan Associates’ common stock as of June 30, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.75%
Tags
ownership

FAQ

How many MANHATTAN ASSOCIATES (MANH) SEC filings are available on StockTitan?

StockTitan tracks 87 SEC filings for MANHATTAN ASSOCIATES (MANH), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for MANHATTAN ASSOCIATES (MANH)?

The most recent SEC filing for MANHATTAN ASSOCIATES (MANH) was filed on November 4, 2026.